Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1806 1
1826 1
1843 1
1902 1
1904 1
1906 1
1913 1
1919 1
1924 1
1925 1
1937 2
1949 3
1950 1
1952 1
1953 1
1954 6
1955 3
1956 4
1957 7
1958 3
1959 6
1960 8
1961 12
1962 8
1963 12
1964 7
1965 5
1966 6
1967 9
1969 4
1970 7
1971 3
1972 2
1973 2
1974 11
1975 15
1976 8
1977 16
1978 16
1979 17
1980 17
1981 20
1982 37
1983 31
1984 26
1985 32
1986 31
1987 36
1988 31
1989 36
1990 38
1991 42
1992 53
1993 58
1994 61
1995 66
1996 64
1997 84
1998 76
1999 61
2000 77
2001 74
2002 66
2003 78
2004 96
2005 97
2006 90
2007 104
2008 105
2009 124
2010 166
2011 135
2012 141
2013 165
2014 183
2015 195
2016 182
2017 214
2018 202
2019 174
2020 217
2021 206
2022 181
2023 200
2024 153
2025 181
2026 105

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,594 results

Results by year

Filters applied: . Clear all
Page 1
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity.
Baumgartner CK, Ebrahimi-Nik H, Iracheta-Vellve A, Hamel KM, Olander KE, Davis TGR, McGuire KA, Halvorsen GT, Avila OI, Patel CH, Kim SY, Kammula AV, Muscato AJ, Halliwill K, Geda P, Klinge KL, Xiong Z, Duggan R, Mu L, Yeary MD, Patti JC, Balon TM, Mathew R, Backus C, Kennedy DE, Chen A, Longenecker K, Klahn JT, Hrusch CL, Krishnan N, Hutchins CW, Dunning JP, Bulic M, Tiwari P, Colvin KJ, Chuong CL, Kohnle IC, Rees MG, Boghossian A, Ronan M, Roth JA, Wu MJ, Suermondt JSMT, Knudsen NH, Cheruiyot CK, Sen DR, Griffin GK, Golub TR, El-Bardeesy N, Decker JH, Yang Y, Guffroy M, Fossey S, Trusk P, Sun IM, Liu Y, Qiu W, Sun Q, Paddock MN, Farney EP, Matulenko MA, Beauregard C, Frost JM, Yates KB, Kym PR, Manguso RT. Baumgartner CK, et al. Among authors: davis tgr. Nature. 2023 Oct;622(7984):850-862. doi: 10.1038/s41586-023-06575-7. Epub 2023 Oct 4. Nature. 2023. PMID: 37794185 Free PMC article.
View from perimenopause.
Thomas L, Davis T, Millar L, Patrick K, Townsend E. Thomas L, et al. Among authors: davis t. Emerg Med J. 2024 Nov 21;41(12):773-774. doi: 10.1136/emermed-2024-214190. Emerg Med J. 2024. PMID: 39393840 No abstract available.
Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator.
Puzio-Kuter AM, Xu L, McBrayer MK, Dominique R, Li HH, Fahr BJ, Brown AM, Wiebesiek AE, Russo BM, Mulligan CL, Yang H, Battaglia J, Robell KA, Thomas DH, Huang KS, Solovyov A, Greenbaum BD, Oliner JD, Davis TW, Dumble ML, Johnson ML, Xiong S, Yang P, Lozano G, Fellous MM, Vu BT, Schram AM, Levine AJ, Poyurovsky MV. Puzio-Kuter AM, et al. Among authors: davis tw. Cancer Discov. 2025 Jun 3;15(6):1159-1179. doi: 10.1158/2159-8290.CD-24-1421. Cancer Discov. 2025. PMID: 39945593 Free PMC article.
Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial.
Rha SY, Zhang Y, Elme A, Pazo Cid R, Alacacioglu A, Ziogas DC, Shitara K, Ranceva A, Nemecek R, Santoro A, Calderon CA, Korphaisarn K, Davis T, Zahlten-Kuemeli A, Conn C, Tan M, Honeycutt H, Wainberg ZA. Rha SY, et al. Among authors: davis t. JCO Precis Oncol. 2025 Jan;9:e2400710. doi: 10.1200/PO-24-00710. Epub 2025 Jan 24. JCO Precis Oncol. 2025. PMID: 39854659 Free PMC article. Clinical Trial.
Potassium-competitive acid blockers.
Davis TA, Gyawali CP. Davis TA, et al. Curr Opin Gastroenterol. 2025 Nov 1;41(6):389-398. doi: 10.1097/MOG.0000000000001127. Epub 2025 Jul 23. Curr Opin Gastroenterol. 2025. PMID: 40923937 Review.
Physiology, Lactation(Archived).
Pillay J, Davis TJ. Pillay J, et al. Among authors: davis tj. 2023 Jul 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2023 Jul 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 29763156 Free Books & Documents.
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint.
Tsao HW, Anderson S, Finn KJ, Perera JJ, Pass LF, Schneider EM, Jiang A, Fetterman R, Chuong CL, Kozuma K, Stickler MM, Creixell M, Klaeger S, Phulphagar KM, Rachimi S, Verzani EK, Olsson N, Dubrot J, Pech MF, Silkworth W, Lane-Reticker SK, Allen PM, Ibrahim K, Knudsen NH, Cheng AY, Long AH, Ebrahimi-Nik H, Kim SY, Du PP, Iracheta-Vellve A, Robitschek EJ, Suermondt JSMT, Davis TGR, Wolfe CH, Atluri T, Olander KE, Rush JS, Sundberg TB, McAllister FE, Abelin JG, Firestone A, Stokoe D, Carr SA, Harding FA, Yates KB, Manguso RT. Tsao HW, et al. Among authors: davis tgr. Immunity. 2024 Dec 10;57(12):2863-2878.e12. doi: 10.1016/j.immuni.2024.10.013. Epub 2024 Nov 18. Immunity. 2024. PMID: 39561763 Free article.
Motion Syros: tradipitant effective in the treatment of motion sickness; a multicenter, randomized, double-blind, placebo-controlled study.
Polymeropoulos VM, Kiely L, Bushman ML, Sutherland EB, Goldberg AR, Pham AX, Miller CR, Mourad R, Davis TR, Pham NV, Morgan DB, Giles AK, Xiao C, Polymeropoulos CM, Birznieks G, Polymeropoulos MH. Polymeropoulos VM, et al. Among authors: davis tr. Front Neurol. 2025 Mar 4;16:1550670. doi: 10.3389/fneur.2025.1550670. eCollection 2025. Front Neurol. 2025. PMID: 40103934 Free PMC article.
4,594 results